Venous thromboembolism risk with Janus kinase inhibitors: Is it a class wide effect?

Expert Opin Drug Saf. 2022 Aug;21(8):1005-1007. doi: 10.1080/14740338.2022.2100343. Epub 2022 Jul 13.

Authors

Ameen Jubber¹, Jonathan Woodward², Hasan Tahir³, Arumugam Moorthy⁴

Affiliations

¹ University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester, UK.
² Royal Free London NHS Foundation Trust, London, UK.
³ Division of Medicine, University College London, London, UK.
⁴ College of Life Sciences, University of Leicester, Leicester, UK.

PMID: 35818715
DOI: 10.1080/14740338.2022.2100343

No abstract available

Publication types

Editorial

MeSH terms

Humans
Janus Kinase Inhibitors* / adverse effects
Risk Factors
Venous Thromboembolism* / chemically induced

Substances

Janus Kinase Inhibitors